UNSPSC 51171901: Cimetidine

This classification denotes a histamine-2 receptor antagonist with the molecular formula C10H16N6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80061L1WGD, chemically known as guanidine, n-cyano-n-methyl-n-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)- but generally known as cimetidine, which bears US NIH Compound Identifier 2756. European Medicines Agency schedules Cimetidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06279MIG.

UNSPSC 51171901 Cimetidine is a Commodity code representing pharmaceutical products—specifically branded and generic acid-reflux and ulcer medications—that state and local governments procure through pharmacy benefit programs, corrections departments, and cooperative purchasing vehicles. Recent activity shows state and local buyers procuring cimetidine as part of broader pharmaceutical supply agreements, generic drug programs, and offender medical testing and treatment services. The issuing bodies span state health and human services agencies, county corrections departments, and multistate cooperative purchasing alliances serving state and local facilities.

Recent opportunities include the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products posted January 20, 2026 with response due March 26, 2026, covering distribution across participating state and local government facilities in Minnesota and Oregon; the Texas Health and Human Services Commission RFI HHS0017013 posted April 3, 2026, exploring direct-to-manufacturer prescription programs for the state's pharmacy benefit program; and Collin County Community Supervision and Corrections Department RFP 2026-327 for offender specimen collection and drug testing services posted July 9, 2026 with response due July 23, 2026, estimating $600,000 in annual testing demand. The MMCAP RFP emphasizes cGMP and Drug Supply Chain Security Act compliance, pricing flexibility through flat, net, or WAC-minus structures, and distribution through authorized wholesalers AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson. Geographic concentration centers on Texas and Minnesota, with broader multistate participation through cooperative purchasing. The code shows modest but active recent solicitation across state pharmacy programs and county correctional healthcare.